Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System and the BeGraft Peripheral Stent Graft System Treating Aortic-iliac Occlusive Disease

RecruitingOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Aorto-iliac Occlusive Disease
Interventions
DEVICE

endovascular intervention

Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) is a new, minimally invasive technique, for treating extensive and/or recurrent aorto-iliac occlusive disease. The technique rebuilds the diseased aortic bifurcation and iliac arteries through the use of stent-grafts introduced through the groin or arm arteries.

Trial Locations (15)

Unknown

RECRUITING

Sankt Gertrauden-Krankenhaus, Berlin

RECRUITING

Universitätsklinikum Frankfurt, Frankfurt

RECRUITING

University Medical Center Goettingen, Göttingen

RECRUITING

Universitätsklinikum Heidelberg, Heidelberg

NOT_YET_RECRUITING

Marienhospital Lünen, Lünen

RECRUITING

St. Franziskus-Hospital GmbH, Münster

RECRUITING

Krankenhaus Barmherzige Brüder Regensburg, Regensburg

RECRUITING

Uniklinikum Regensburg, Regensburg

RECRUITING

Klinikum der Landeshauptstadt Stuttgart gKAöR, Stuttgart

RECRUITING

Noordwest Ziekenhuisgroep Alkmaar, Alkmaar

RECRUITING

Ziekenhuis Rijnstate Arnhem, Arnhem

RECRUITING

Martini Ziekenhuis, Groningen

RECRUITING

UMCG Groningen, Groningen

RECRUITING

Maastricht UMC+, Maastricht

RECRUITING

HMC (Haaglanden Medisch Centrum), The Hague

All Listed Sponsors
lead

Marc Bosiers, MD

OTHER